Related Articles
Considerations on development, validation, application, and quality control of immuno(metric) biomarker assays in clinical cancer research: An EORTC-NCI working group report
A pilot study of Auron Misheil Therapy in patients with advanced cervical cancer: Tumor response and its correlation with clinical benefit response, and preliminary quality of life data
Twenty years of experience with the steroid receptor external quality assessment program - the paradigm for tumour biomarker EQA studies. On behalf of the EROTC Receptor and Biomarker Study Group.
Impact of post‑operative hormone replacement therapy on life quality and prognosis in patients with ovarian malignancy
ADJUVANT TREATMENT OF COLON-CANCER - A PLEA FOR A LARGE-SCALE EUROPEAN TRIAL